Literature DB >> 20376705

Contribution of SELP and PSGL-1 genotypes and haplotypes to the presence of coronary heart disease in Tunisians.

Lakhdar Ghazouani1, Nesrine Abboud, Sonia Ben Hadj Khalifa, Claire Perret, Viviane Nicaud, Wassim Youssef Almawi, François Cambien, Touhami Mahjoub.   

Abstract

P-selectin (SELP) and its counter-receptor, P-selectin glycoprotein ligand-1 (PSGL-1), play key role in the transient attachment of leukocytes to endothelial cells predisposing to coronary heart disease (CHD). In the current report, 293 angiographically proven CHD patients and 327 age, gender, and race-matched controls were included. Our aim was to evaluate the contribution to CHD of the following SNPs: C-2123G, G-1969A and T715P in SELP, Met62Ile and the VNTR variants in PSGL-1 gene in a North African population from Tunisia. While there were no significant differences in the distribution of SELP or PSGL-1 alleles or genotypes between patients and controls, a trend for a significant association of the C-2123G genotypes distribution with incident CHD was observed (P=0.06). Assuming an additive model of transmission, the risk was 74% higher among subjects carrying the GG genotypes in comparison to those carrying the CC genotype (OR=1.74 [1.01-2.98], P=0.04) and 80% higher in the recessive model (OR=1.80 [1.08-3.01], P=0.02). Haplotype analysis did not identify any specific SELP or PSGL-1 haplotypes to be associated with CHD. The present study demonstrated no evidence of association between individual SELP or PSGL-1 SNPs or haplotypes with incident CHD. However, this study replicates absence of association of the mostly studied SNP, T715P, previously reported in individuals with African origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376705     DOI: 10.1007/s11033-010-0133-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease.

Authors:  A M Carter; K Anagnostopoulou; M W Mansfield; P J Grant
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

2.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study. Etude cas-temoin de l'infarctus myocarde.

Authors:  F Kee; C Morrison; A E Evans; E McCrum; D McMaster; J Dallongeville; V Nicaud; O Poirier; F Cambien
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

4.  Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.

Authors:  A Kumar; M P Villani; U K Patel; J C Keith; R G Schaub
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

5.  Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease.

Authors:  Peter Bugert; Marion Vosberg; Mathias Entelmann; Jürgen Jahn; Hugo A Katus; Harald Klüter
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

Review 6.  Pathophysiology of coronary artery disease.

Authors:  Peter Libby; Pierre Theroux
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

7.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin.

Authors:  P S Frenette; R C Johnson; R O Hynes; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

8.  Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians.

Authors:  Manickaraj AshokKumar; Navaneethan Gnana Veera Subhashini; Ramineni SaiBabu; Arabandi Ramesh; Kotturathu Mammen Cherian; Cyril Emmanuel
Journal:  Mol Biol Rep       Date:  2009-08-22       Impact factor: 2.316

9.  Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Kelly A Volcik; Christie M Ballantyne; Josef Coresh; Aaron R Folsom; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2007-04-08       Impact factor: 5.162

10.  SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease.

Authors:  D A Tregouet; S Barbaux; O Poirier; S Blankenberg; C Bickel; S Escolano; H J Rupprecht; J Meyer; F Cambien; L Tiret
Journal:  Ann Hum Genet       Date:  2003-11       Impact factor: 1.670

View more
  5 in total

1.  SELP genetic polymorphisms may contribute to the pathogenesis of coronary heart disease and myocardial infarction: a meta-analysis.

Authors:  Dong-Hui Zhou; Yong Wang; Wei-Na Hu; Li-Jie Wang; Qi Wang; Miao Chi; Yuan-Zhe Jin
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

2.  Correlations of SELE and SELP genetic polymorphisms with myocardial infarction risk: a meta-analysis and meta-regression.

Authors:  Yu-Juan Zhao; Xia Yang; Li Ren; An-Sheng Cai; Yan-Fen Zhang
Journal:  Mol Biol Rep       Date:  2014-03-18       Impact factor: 2.316

3.  Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis.

Authors:  Hong-Qiang Liu; Chang-Po Zhang; Chang-Zhen Zhang; Xiang-Chen Liu; Zun-Jing Liu
Journal:  Biomed Res Int       Date:  2015-01-06       Impact factor: 3.411

4.  Plasma P-selectin level is associated with severity of coronary heart disease in Chinese Han population.

Authors:  Chunhui Song; Guohai Wu; Sheng Chang; Lizhan Bie
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

5.  Heterogeneous effect of two selectin gene polymorphisms on coronary artery disease risk: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Lin Lu; Yan Liu; Qiujing Chen; Xin Chen; Wei Jin
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.